Stay updated on Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.

Latest updates to the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page
- ChecktodayChange DetectedRevision: v3.4.2 was added; the notice about government funding interruptions and the prior Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check7 days agoChange DetectedA site-wide notice about government funding and NIH operations was added, and the page shows a new revision label (v3.4.1) replacing the previous (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check15 days agoChange DetectedAdds a new 'Show glossary' toggle and standardizes metadata labels, including 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', plus a new site Revision: v3.4.0. The previous variants 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' are removed.SummaryDifference0.2%

- Check29 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This represents a site version update with no changes to the study data or page content.SummaryDifference0.1%

- Check50 days agoChange DetectedA new Locations section appears with Zhejiang (Hangzhou, China) and the page revision updates to v3.3.3; the previous Zhejiang Locations entry and HHS Vulnerability Disclosure link were removed.SummaryDifference0.2%

- Check79 days agoChange DetectedThe page shows a minor revision update from v3.2.0 to v3.3.2 without changes to the study content or parameters. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Camrelizumab for Colorectal Mucinous Adenocarcinoma Clinical Trial page.